Clinical Trial Update: Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001

View source ↗

Summary

Clinical trial update reporting molecular, genetic, and genomic assessments from patients with metastatic castration-resistant prostate cancer treated with ever…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Everolimus (RAD001) (everolimus)

Snippet

Sponsor: Duke University | Conditions: Metastatic Hormone Refractory Prostate Cancer | Status: COMPLETED